T-CELL LYMPHOMA
Clinical trials for T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Lymphoma drug duvelisib tested as Post-Transplant maintenance
Disease control TerminatedThis Phase 2 trial tested the drug duvelisib (Copiktra) as a maintenance therapy after autologous stem cell transplant in 17 adults with T-cell lymphoma. The goal was to see if it is safe and improves progression-free survival. The study was terminated early, so results are limit…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC
-
Early trial of tazemetostat for tough T-Cell lymphoma halted after just 6 patients
Disease control TerminatedThis early-phase study tested the safety of a drug called tazemetostat in people with a type of blood cancer called peripheral T-cell lymphoma that had returned or stopped responding to other treatments. Only 6 participants were enrolled before the study was stopped early. The go…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 18, 2026 11:53 UTC